XML 43 R32.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT DATA AND RELATED INFORMATION (Tables)
9 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of segment data and related information
Three Months Ended
March 31,
Nine Months Ended
March 31,
(In millions)2025202420252024
PRODUCT CATEGORY DATA
Net sales:
Skin Care$1,807 $2,060 $5,257 $5,873 
Makeup1,035 1,136 3,223 3,365 
Fragrance557 575 1,931 1,948 
Hair Care126 143 424 464 
Other25 26 80 88 
3,550 3,940 10,915 11,738 
Returns associated with restructuring and other activities— — — (1)
Net sales$3,550 $3,940 $10,915 $11,737 
Operating income (loss) before charges associated with restructuring and other activities:
Skin Care$361 $468 $784 $920 
Makeup14 66 (382)56 
Fragrance32 29 (354)267 
Hair Care(13)(25)(34)(50)
Other11 (25)38 
403 549 (11)1,231 
Reconciliation:
Charges associated with restructuring and other activities(97)(18)(384)(28)
Interest expense(87)(94)(269)(287)
Interest income and investment income, net27 45 85 126 
Other components of net periodic benefit cost(5)(10)
Earnings (loss) before income taxes$241 $486 $(589)$1,051 
GEOGRAPHIC DATA(1)
Net sales:
The Americas$1,052 $1,117 $3,462 $3,567 
Europe, the Middle East & Africa1,358 1,647 4,082 4,488 
Asia/Pacific1,140 1,176 3,371 3,683 
3,550 3,940 10,915 11,738 
Returns associated with restructuring and other activities— — — (1)
Net sales$3,550 $3,940 $10,915 $11,737 
Operating income (loss):
The Americas$$(6)$(983)$(243)
Europe, the Middle East & Africa239 302 645 825 
Asia/Pacific156 253 327 649 
403 549 (11)1,231 
Charges associated with restructuring and other activities(97)(18)(384)(28)
Operating income (loss)$306 $531 $(395)$1,203 
(1) The net sales from the Company's travel retail business are included in the Europe, the Middle East & Africa region, and operating income attributable to these net sales are included in that region and in The Americas. The exception is for net sales and operating income of Dr.Jart+ in the travel retail channel in Korea that are reflected in Korea in the Asia/Pacific region. During the fiscal 2025 second quarter, the Company exited Dr.Jart+ from the travel retail channel in Korea.